The second most used diagnostic biomarker for PDAC is carcinoembryonic antigen (CEA), a glycoprotein that was originally identified as a biomarker for colorectal cancer and has since been evaluated as a diagnostic marker for several cancers [61,62]. This evidence concerns the gene CEACAM5 and colorectal cancer.